Kiandokht Borhani

[ 1 ] - Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant

Background: Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers have shown that lenalidomide is capable of ameliorating the immune system factors and antitumor responses. Most researchers have reported that lenalidomide enhances the immune response in certain cancer patients through sever...